Kolkata News Today

U.S. Contraceptive Market Is Projected To Register A Healthy CAGR Of 4.2% From 2020 To 2027 | Grand View Research, Inc.

 Breaking News
  • No posts were found

U.S. Contraceptive Market Is Projected To Register A Healthy CAGR Of 4.2% From 2020 To 2027 | Grand View Research, Inc.

February 25
09:05 2020
U.S. Contraceptive Market Is Projected To Register A Healthy CAGR Of 4.2% From 2020 To 2027 | Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The U.S. contraceptive market size was valued at around USD 7 billion in 2019 and is projected to expand at a CAGR of around 4.2% over the forecast period.

The U.S. contraceptive market size is expected to reach USD 9.6 billion by 2027, exhibiting a 4.2% CAGR over the forecast period, based on a new report published by Grand View Research, Inc. Improving awareness regarding Long-Acting Reversible Contraceptives (LARCs) and effectiveness, availability, and convenience of using these products are the factors expected to drive the growth. The Guttmacher Institute reports that in U.S., 60% of women of reproductive age use contraception. Use of hormonal contraceptives other than the birth control pill has significantly increased among married women.

Key market players are actively investing in the clinical pipeline, resulting in high competition and an increase in the quality of contraceptives. In January 2019, Mithra Pharmaceuticals announced the success of Estelle’s phase 3 study conducted in U.S. and Canada, meeting the primary efficacy endpoint. The efficacy was reported to be similar to a recently FDA-approved Annovera and Lo-Loestrin. In November 2019, Agile Therapeutics, Inc. announced that the U.S. FDA had extended the review date of Twirla’s New Drug Application (NDA), from November 16, 2019 to February 16, 2020.

To Know More About U.S. Contraceptive Market, Access Sample Report @ https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market/request/rs1

U.S. contraceptive market size, by product, 2016 - 2027, (USD Billion)

Further key findings from the study suggest:

  • Prevalence of teenage pregnancies is highest in U.S. among developed nations. Government initiatives such as improving sex education and increasing access to contraceptives is expected to drive adoption of various birth control method among young population
  • In 2019, the pills segment held the largest market share owing to the convenience of use and easy availability. The pills market is highly competitive due to the presence of generic products
  • Intrauterine Devices (IUDs) held one of the largest market shares in 2019, with increasing demand for hormonal IUDs
  • Rapid growth of subdermal implants in the U.S. contraceptive market is anticipated in the coming years. The market for subdermal implants is highly consolidated with presence of very few players
  • Nonhormonal birth control methods such as condoms, sponge, and diaphragms are popular among women in the age group of 25 to 40 years
  • Some of the key industry contributors are Merck & Co. Inc.; Bayer AG; Allergan, Afaxys, Inc; Mayer Laboratories, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; TherapeuticsMD Inc.; Reckitt Benckiser Plc.; Pfizer, Inc.; Cooper Surgical; Church & Dwight Co., Inc.; Mithra Pharmaceuticals

U.S. contraceptive market share, by product, 2019 (%)

Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market

Grand View Research has segmented the U.S. contraceptive market based on product:

U.S. Contraceptive Product Outlook(Revenue, USD Million, 2016 – 2027)

  • Pills
  • Condoms
    • Male Condoms
    • Female Condoms
    • Diaphragms
    • Sponge
    • Vaginal Ring
    • Subdermal Implants
    • IUD
      • Hormonal IUD
      • Nonhormonal IUD
    • Patch
    • Injectable

 Key Topics Covered 

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Objectives
                       1.1.1. Objective – 1
                       1.1.2 Objective – 2
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                       2.2.1 Product
                   2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage outlook
                       3.1.1 Parent Market Outlook
                   3.2 Market Segmentation
                   3.3 Market Dynamics
                       3.3.1 Market Driver Analysis
                           3.3.1.1 Technological advancements
                           3.3.1.2 Initiatives by social organizations to improve the access of condom to avoid Sexually Transmitted Diseases (STDs)
                           3.3.1.3 Increasing Prevalance of unwanted pregnancies
                       3.3.2 Market Restraint Analysis
                           3.3.2.1 Increasing geriartic population and rising prevalence of infertility
                           3.3.2.2 Adverse effects associated with use of contraceptive drugs and devices
                   3.4 Business Environment Analysis Tools
                       3.4.1 Porter’s Five Forces Analysis
                       3.4.2 PESTEL Analysis
                   3.5 Penetration & Growth Prospect Mapping

…. continue

Browse Related Reports :
Hormonal Contraceptive Market
By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, And Segment Forecasts, 2019 – 2026:

https://www.grandviewresearch.com/industry-analysis/hormonal-contraceptive-market

Subdermal Contraceptive Implants Market By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 – 2026:

https://www.grandviewresearch.com/industry-analysis/subdermal-contraceptive-implants-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market